Home  >  Products  >  NCOA3 (nuclear receptor coactivator 3) Blocking Peptide (the N terminal of NCOA3)(100ug)
NCOA3 (nuclear receptor coactivator 3) Blocking Peptide (the N terminal of NCOA3)(100ug)

NCOA3 (nuclear receptor coactivator 3) Blocking Peptide (the N terminal of NCOA3)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-NCOA3 Antibody(ARP32486_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP32486
Size: 100ug
Weight: 155kDa
Gene: 8202
Format: Lyophilized powder
Target: NCOA3 is a nuclear receptor coactivator that interacts with nuclear hormone receptors to enhance their transcriptional activator functions. The encoded protein has histone acetyltransferase activity and recruits p300/CBP-associated factor and CREB binding protein as part of a multisubunit coactivation complex. This protein is initially found in the cytoplasm but is translocated into the nucleus upon phosphorylation. Two transcript variants encoding different isoforms have been found for this gene. In addition, a polymorphic repeat region is found in the C-terminus of the encoded protein.
Alternative names: ACTR; AIB-1; AIB1; CAGH16; CTG26; KAT13B; MGC141848; RAC3; SRC-1; SRC3; TNRC14; TNRC16; TRAM-1; pCIP
See Full Product Listings >